You are here

Article info

Article menu
Download PDFPDF
Therapeutics/Prevention
Randomised controlled trial
Four-month fluoroquinolone-containing regimens are inferior to standard 6-month tuberculosis treatment

Authors

  1. Correspondence to : Dr Timothy Sterling, A2209 Medical Center North, 1161 21st Avenue South, Nashville, TN 37232, USA; timothy.sterling{at}vanderbilt.edu
View Full Text

Citation

Sterling TR
Four-month fluoroquinolone-containing regimens are inferior to standard 6-month tuberculosis treatment
BMJ Evidence-Based Medicine 2015;20:128-129.

Publication history

  • First published April 29, 2015.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions